Bone Marrow Failure Disease Consortium News

BMFC News and Events

Aplastic Anemia & MDS International Foundation, Inc. News

Aplastic Anemia & MDS International Foundation, Inc. Media and Press Information

Aplastic Anemia & MDS International Foundation, Inc Patient and Family Conference

2007

11.28.07 - Featured Article: On the Trail of Rare Disease by Pete Thompson. The New Physician, Nov 07

2006

05.05.06 - NIH Launches Clinical Studies Nationwide to Investigate Rare Diseases

05.03.06 - Dacogen® (decitabine) Approved by the FDA for Patients With All Subtypes of Myelodysplastic Syndromes (MDS)

01.05.06 - Tampa Tribune: "Patients, Moffitt See New Drug's Benefit" by Carol Gentry

2005

12.28.2005 - Revlimid® (lenolidomide) approved by the FDA for patients with a subgroup of myelodysplastic syndromes (MDS)

11.03.2005 - Once-Daily Oral Iron Chelator Exjade® Receives Approval in the U.S.

10.19.2005 - Bone Marrow Diseases Scientific Symposium: Summary & Abstracts - Request Your Free Copy from the Aplastic Anemia & MDS International Foundation

2004

05.19.2004 - FDA Approves Pharmion's Vidaza(TM) for the Treatment of MDS

2003

11.14.2003 - Bone Marrow Failure Consortium Steering Committee Meeting

10.5.2003 - Press Release - Cleveland Clinic Taussig Cancer Center Receives $4.5 Million Grant to Establish Bone Marrow Failure Clinical Research Center [Word .doc 52KB]